**Core Concept**
Hand and foot syndrome, also known as palmar-plantar erythrodysesthesia, is a common adverse effect of certain chemotherapeutic agents. This condition is characterized by erythema, edema, and sometimes peeling of the skin on the palms and soles.

**Why the Correct Answer is Right**
The pathophysiology of hand and foot syndrome is believed to involve damage to the rapidly dividing cells of the skin and mucosa, leading to inflammation and tissue damage. Chemotherapeutic agents such as 5-fluorouracil (5-FU), capecitabine, and other pyrimidine analogs are known to cause this condition by inhibiting thymidylate synthase, an enzyme crucial for DNA synthesis. This results in the accumulation of toxic metabolites, which in turn cause damage to the skin and mucosa.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because, although other drugs like taxanes and anthracyclines can cause hand-foot syndrome, they are not the most commonly associated agents.
* **Option B:** This option is incorrect because, while certain antibiotics like doxorubicin can cause hand-foot syndrome, it is not the most characteristic or common association.
* **Option C:** This option is incorrect because, although some tyrosine kinase inhibitors can cause hand-foot syndrome, they are not the primary drugs associated with this condition.

**Clinical Pearl / High-Yield Fact**
The severity of hand and foot syndrome can be mitigated by administering chemotherapeutic agents with a lower dose intensity, using protective measures such as moisturizing creams, and employing other supportive care strategies to minimize skin damage.

**Correct Answer: C. 5-fluorouracil (5-FU)**